Liver Steatosis and Cardiovascular Risk Markers in Rheumatoid Arthritis Patients

A 2026 cross-sectional study of 51 patients with rheumatoid arthritis (46 women; mean age 48.8 years) from figshare. The data sheet contains measurements for liver fat scores, organokine levels, cardiovascular risk scores, and echocardiographic parameters to explore associations with metabolic dysfunction-associated steatotic liver disease (MASLD).

Use Cases

• Evaluate the diagnostic performance of the Fatty Liver Index (FLI) and Hepatic Steatosis Index (HSI) for MASLD based on the reported AUC values.
• Investigate associations between organokine levels (e.g., FABP4, FGF21) and liver disease risk in a rheumatoid arthritis cohort.
• Analyze relationships between liver fat scores, neutrophil-to-lymphocyte ratio, and cardiovascular risk parameters mentioned in the description.
• Explore potential biomarkers for left ventricular diastolic dysfunction linked to metabolic liver disease.

Strengths

• Includes specific diagnostic performance metrics (e.g., FLI AUC 0.81, FABP4 AUC 0.82) for biomarker evaluation.
• Reports detailed clinical and laboratory measures for 51 patients, including disease duration and demographic breakdown.
• Data is shared under a permissive CC-BY-4.0 license, facilitating reuse.

Limitations

• The dataset is small (51 patients) and exploratory, limiting statistical power and generalizability.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for some modeling tasks.

Provenance

Source

figshare, author Mariusz Ciołkiewicz.

Collection Method

Cross-sectional, exploratory clinical study.

Freshness

Last updated 2026-05-29 04:49:03; freshness should be verified.